Tuesday, September 20, 2016

State pushing uncooperative Mylan over EpiPen

West Virginia Attorney General Patrick Morrisey is pushing its investigative subpoena against an uncooperative Mylan Pharmaceuticals over the Mylan EpiPen exobitant price hike.
Morrisey said the company initially agreed to cooperate, but has failed to respond to the majority of the subpoena.
The subpoena inquires about the increasing price, alleged failed attempts on Mylan's behalf to introduce an EpiPen competitor, litigation over intellectual property, the dominance Mylan has over the epinephrine auto injector market, and rebates Mylan paid to participate in the state's Medicaid program. 
Mylan paid cheaper “non-innovator” drug rebate amount instead of the correct “innovator” amount.
After Mylan got exclusive rights to market the EpiPen, which was developed at no cost to Mylan by the federal government, in 2007, it skyrocked the price for a pair from $100 to $600.
Mylan CEO Heather Bresch is U.S. Senator Joe Manchin’s daughter. The West Virginia politician has not replied substantially to Mylan putting profits over shoving taxpayers and patients into financial distress over the life-saving device.

No comments:

Post a Comment